Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis

计划入组 158 人 · 首次发布于 2016 年 4 月 27 日

Teva Asthma Predictive Analytics Study

计划入组 100 人 · 首次发布于 2021 年 8 月 9 日

BIONICS Israel Trial

计划入组 58 人 · 首次发布于 2016 年 7 月 15 日

scFv-F240 (Beth Israel)

Synthetic conjugated estrogen(Teva)

Denosumab biosimilar(Teva Pharma)

Teva Pharma B.V.

Netherlands

Teva Pharmaceutical Industries

Israel

Teva GmbH

Germany

Prestige Biopharma Partners with Teva Israel for Trastuzumab Biosimilar Commercialization

Clinical Trial Highlights Positive Effects of Medical Cannabis on PTSD

Teva and Sheba Medical Center Forge Strategic Partnership to Accelerate Israeli Health Tech Innovation Globally